TAT Technologies Stock Climbs After Benchmark Initiates Coverage with 'Buy' Rating
Benchmark initiated coverage on TAT Technologies Ltd. (NASDAQ:TATT) with a 'Buy' rating on November 17, 2025, signaling a positive outlook for the aerospace and defense services provider. Following the announcement, the company's stock was priced at $40.04, a 0.65% increase, with a trading volume of 136,570 shares on the NASDAQ exchange.
The new rating follows the company's third-quarter 2025 earnings report, released on November 13, 2025. During the earnings call, CEO Igal Zamir highlighted continued organic growth that surpassed the broader Maintenance, Repair, and Overhaul (MRO) market. Zamir attributed the performance to a rebound in Auxiliary Power Unit (APU) activity and contributions from its landing gear maintenance division.
Based in Netanya, Israel, TAT Technologies specializes in MRO services for the aerospace and ground defense sectors, focusing on what it identifies as underserved market segments. The company's diversified business model has positioned it as a key partner for carriers.
Over the past year, TAT Technologies' stock has traded between a low of $20 and a high of $45.83. The company currently holds a market capitalization of approximately $518.5 million. Investors can find the full Q3 2025 earnings call transcript on Seeking Alpha for more details.
For more information on TAT Technologies, see:
- Company History, Mission, and Ownership
- Mission and Vision
- Financial Health Analysis
- Investor Profile
TAT Technologies Ltd. (TATT) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.